MYL5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.404600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.952600E-01
Normal-vs-Stage2
8.255000E-01
Normal-vs-Stage3
5.815600E-01
Normal-vs-Stage4
1.674750E-01
Stage1-vs-Stage2
5.374400E-01
Stage1-vs-Stage3
4.902600E-01
Stage1-vs-Stage4
2.307000E-01
Stage2-vs-Stage3
9.416600E-01
Stage2-vs-Stage4
1.091770E-01
Stage3-vs-Stage4
3.249800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.600200E-01
Normal-vs-AfricanAmerican
2.769600E-01
Normal-vs-Asian
2.593600E-01
Caucasian-vs-AfricanAmerican
6.771600E-01
Caucasian-vs-Asian
1.881570E-01
AfricanAmerican-vs-Asian
1.696250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.672200E-01
Normal-vs-Female
9.284000E-01
Male-vs-Female
4.452800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.516200E-01
Normal-vs-Age(41-60Yrs)
3.209600E-01
Normal-vs-Age(61-80Yrs)
9.251600E-01
Normal-vs-Age(81-100Yrs)
5.645000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.814400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.618800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.560200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.109200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.889000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.902200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.208000E-01
Normal-vs-Daily Drinker
7.885200E-01
Normal-vs-Weekly Drinker
3.436400E-01
Normal-vs-Occasional Drinker
3.478400E-01
Normal-vs-Social Drinker
7.645200E-01
Non Drinker-vs-Daily Drinker
2.027200E-01
Non Drinker-vs-Weekly Drinker
3.694400E-01
Non Drinker-vs-Occasional Drinker
7.589000E-01
Non Drinker-vs-Social Drinker
4.413400E-01
Daily Drinker-vs-Weekly Drinker
1.459010E-01
Daily Drinker-vs-Occasional Drinker
1.832250E-01
Daily Drinker-vs-Social Drinker
3.484600E-01
Weekly Drinker-vs-Occasional Drinker
7.289600E-01
Weekly Drinker-vs-Social Drinker
2.116000E-01
Occasional Drinker-vs-Social Drinker
3.716200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.778000E-01
Normal-vs-Grade 2
5.999800E-01
Normal-vs-Grade 3
3.438000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.127800E-01
Grade 1-vs-Grade 3
4.694400E-01
Grade 1-vs-Grade 4
3.778000E-01
Grade 2-vs-Grade 3
1.892180E-01
Grade 2-vs-Grade 4
5.999800E-01
Grade 3-vs-Grade 4
3.438000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.671000E-01
Normal-vs-NonDiabetic
8.501600E-01
Diabetic-vs-NonDiabetic
7.999400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.662200E-01
Normal-vs-NoPancreatitis
9.196800E-01
Pancreatitis-vs-NoPancreatitis
7.958200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.414800E-01
Normal-vs-N1
6.775200E-01
N0-vs-N1
2.108400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.880000E-01
Normal-vs-TP53-NonMutant
7.240400E-01
TP53-Mutant-vs-TP53-NonMutant
6.309400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
